Yangyang Huang
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Small-volume plan optimization of inoperable early-stage centrally-located non-small-cell lung cancer using VMAT-based SBRT under the DIBH scenario: a single-arc model or a dual-arc plan?
Journal: Frontiers in oncology
Published: October 04, 2025
METTL1 mediates m7G modification of PFKFB3 mRNA to promote radioresistance in esophageal cancer by affecting glycolytic metabolism.
Journal: Pathology, research and practice
Published: May 19, 2025
Novel DCAT plans in stereotactic body radiotherapy for stage I/II centrally located non-small-cell lung cancer.
Journal: Scientific reports
Published: September 23, 2024
Exosome-Shuttled METTL14 From AML-Derived Mesenchymal Stem Cells Promotes the Proliferation and Radioresistance in AML Cells by Stabilizing ROCK1 Expression via an m6A-IGF2BP3-Dependent Mechanism.
Journal: Drug development research
Published: August 07, 2024
Treating early-stage centrally-located non-small cell lung cancer with DCAT-SBRT in centers lacking the VMAT technique: a comprehensive study.
Journal: Frontiers in oncology
Published: May 11, 2024
Clinical evaluation of the convolutional neural network‑based automatic delineation tool in determining the clinical target volume and organs at risk in rectal cancer radiotherapy.
Journal: Oncology letters
Published: March 04, 2024
Impact of ovary-sparing treatment planning on plan quality, treatment time and gamma passing rates in intensity-modulated radiotherapy for stage I/II cervical cancer.
Journal: Medicine
Published: December 20, 2023
Continuing Cetuximab vs Bevacizumab plus chemotherapy after first progression in wild-type KRAS, NRAS and BRAF V600E metastatic colorectal cancer: a randomized phase II trial.
Journal: Journal of Cancer
Published: March 02, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026